0000730464false0000730464exch:XNYS2025-01-302025-01-300000730464exch:XCHI2025-01-302025-01-3000007304642025-01-302025-01-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 30, 2025

ADTALEM GLOBAL EDUCATION INC.

(Exact name of registrant as specified in its charter)

 

Delaware

001-13988

36-3150143

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

 

 

500 West Monroe

Chicago, IL

 

60661

(Address of principal executive offices)

 

(Zip Code)

(312) (651-1400)

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of each exchange on
which registered

Common Stock $0.01 Par Value

ATGE

New York Stock Exchange

Common Stock $0.01 Par Value

ATGE

Chicago Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 2.02Results of Operations and Financial Condition

On January 30, 2025, Adtalem Global Education Inc. (“Adtalem”) issued a press release announcing its second quarter fiscal 2025 academic, operating and financial results. The press release is attached hereto as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

The information furnished pursuant to this Item 2.02, including Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Adtalem under the Securities Act of 1933, as amended, or the Exchange Act.

Cautionary Disclosure Regarding Forward-Looking Statements

Certain statements contained in this Form 8-K and related press release are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, which includes statements regarding Adtalem’s future growth. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “future,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “may,” “will,” “would,” “could,” “can,” “continue,” “preliminary,” “range,” and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include the risk factors described in Item 1A. “Risk Factors” of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC. These forward-looking statements are based on information available to us as of the date any such statements are made, and Adtalem assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized, except as required by law.

Item 9.01Financial Statements and Exhibits.

99.1

    

Press release of Adtalem Global Education Inc. dated January 30, 2025.

104

Cover Page Interactive Data File (formatted in Inline XBRL and included as Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ADTALEM GLOBAL EDUCATION INC.

By:

/s/ Robert J. Phelan

Robert J. Phelan

Senior Vice President and Chief Financial Officer

(Principal Financial Officer)

Date: January 30, 2025

Exhibit 99.1

News Release

Graphic

Investor Contact

Jay Spitzer

Investor.Relations@Adtalem.com

+1 312-906-6600

Media Contact

Britt Mitchell

AdtalemMedia@Adtalem.com

+1 872-270-0301

Adtalem Global Education Second Quarter Fiscal Year 2025 Results; Guidance Raised

Total enrollment up 11.6% YoY

Revenue up 13.9% YoY

Diluted earnings per share $1.98; Adjusted EPS $1.81, growth of 47.2% YoY

Second quarter highlights

Total student enrollment 91,264, up 11.6% year-over-year
Revenue $447.7 million, up 13.9% year-over-year
Chamberlain University achieved eighth straight quarter of total enrollment growth, up 11.5% year-over-year, highest total enrollment in university history
Walden University achieved sixth straight quarter of total enrollment growth, up 13.2% year-over-year
Strong momentum, GAAP net income $75.9 million and adjusted EBITDA $125.0 million, up 35.1% year-over-year
Growth with Purpose strategy generating significant and sustainable returns

Capital allocation

Repurchased $38 million of shares, $140 million remaining under $300 million Board authorized share repurchase program through January 2027
Repaid $100 million of outstanding Term Loan B balance on Jan. 17, 2025
Net leverage 1.1x as of Dec. 31, 2024

Fiscal year 2025 guidance

Revenue $1,730 million to $1,760 million
Adjusted earnings per share $6.10 to $6.30

CHICAGO – Jan. 30, 2025 – Adtalem Global Education Inc. (NYSE: ATGE), the leading healthcare educator in the United States, today reported second quarter fiscal year 2025 results (ended Dec. 31, 2024), expanding the Company’s societal and healthcare impact at an industry-leading pace.

"Growth with Purpose, our operational excellence strategy, has delivered exceptional results—marked by six straight quarters of enrollment growth—while advancing our mission to develop skilled healthcare professionals," said Steve Beard, chairman and chief executive officer, Adtalem Global Education. "By optimizing the student experience and with a commitment to student outcomes, we're successfully scaling critical care education. These consistent and sustainable results give us confidence to raise our expectations for fiscal 2025."

Financial Highlights

Selected financial data for the three months ended Dec. 31, 2024:

Revenue of $447.7 million increased 13.9% compared with the prior year
Operating income of $103.9 million, compared with $58.6 million in the prior year; adjusted operating income of $101.4 million, compared with $75.6 million in the prior year
Net income of $75.9 million, compared with $39.9 million in the prior year; adjusted net income of $69.4 million, compared with $50.3 million in the prior year
Diluted earnings per share of $1.98, compared with $0.98 in the prior year; adjusted earnings per share of $1.81, compared with $1.23 in the prior year
Adjusted EBITDA of $125.0 million, compared with $92.6 million in the prior year; adjusted EBITDA margin of 27.9%, compared with 23.5% in the prior year

Business Highlights

Adtalem produced more graduates with Psychiatric-Mental Health Nurse Practitioner (MSN-PMHNP) degrees than the top 20 programs combined, according to the most recently published 2023 data from the American Association of Colleges of Nursing. Adtalem is addressing critical U.S. healthcare issues, as The National Institute for Health Care Management estimates that approximately 49% of Americans live in a mental health workforce shortage area. As of Dec. 31, 2024, Chamberlain University enrolled over 3,000 MSN-PMHNP students, with Walden University enrolling over 6,600. Further, Walden University currently has over 21,000 students enrolled in Social and Behavioral Sciences programs.
Chamberlain University continues to build a robust pipeline of nurses through programs including its Bachelor of Science in Nursing (BSN) Online Option, which offers flexibility and experiential learning opportunities to students in 36 states. The program boasts over 2,500 current enrollees since launching four years ago and operates 44 clinical hub locations at partner healthcare sites.

Walden University launched "Get the W," a new brand campaign that celebrates the wins that drive our students and graduates to make a meaningful impact in healthcare and beyond.
Ross University School of Veterinary Medicine (RUSVM) hosted the West Indies Veterinary Conference 2024, a prominent event in the global veterinary community that brings together hundreds of veterinary professionals, including over 300 RUSVM alumni. The event featured continuing education, including lectures and master classes on topics ranging from wound care to business management.

Segment Highlights

Chamberlain

$ in millions

Three Months Ended

December 31,

2024

2023

% Change

Revenue

$181.0

$153.6

17.9%

Operating Income

$42.2

$29.6

42.5%

Adj. Operating Income

$42.3

$29.6

42.7%

Adj. EBITDA

$52.6

$36.9

42.5%

Total Students (1)

39,691

35,592

11.5%

Total student enrollment increased 11.5% compared with the prior year, driven by continued growth in pre-licensure and post-licensure nursing programs.


Walden

$ in millions

Three Months Ended

December 31,

2024

2023

% Change

Revenue

$171.3

$146.8

16.7%

Operating Income

$48.9

$21.6

126.4%

Adj. Operating Income

$46.2

$30.2

53.1%

Adj. EBITDA

$52.1

$34.6

50.2%

Total Students (1)

46,399

40,971

13.2%

Total student enrollment increased 13.2% compared with the prior year, driven by growth in healthcare and non-healthcare programs.

Medical and Veterinary

$ in millions

Three Months Ended

December 31,

2024

2023

% Change

Revenue

$95.4

$92.9

2.8%

Operating Income

$21.5

$22.0

(2.5)%

Adj. Operating Income

$21.5

$22.1

(2.6)%

Adj. EBITDA

$26.7

$26.4

1.3%

Total Students (1)

5,174

5,209

(0.7)%

Medical and Veterinary schools do not have a new enrollment period starting in the second quarter fiscal year 2025. Second quarter fiscal year 2025 enrollment period is the same as first quarter fiscal year 2025 enrollment period and corresponding reported enrollment data.

Fiscal Year 2025 Outlook

Adtalem raises guidance for fiscal year 2025, with revenue in the range of $1,730 million to $1,760 million, approximately 9.0% to 11.0% growth year-over-year. Adjusted earnings per share to be in the range of $6.10 to $6.30, approximately 21.5% to 25.5% growth year-over-year.


Conference Call and Webcast Information

Adtalem will hold a conference call to discuss its second quarter fiscal year 2025 results today at 4:00 p.m. CT (5:00 p.m. ET).

The call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating “Adtalem earnings call” or by using conference ID: 13750710. The call will be simulcast through the Adtalem investor relations website at: https://investors.adtalem.com.

Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13750710, or visit the Adtalem investor relations website.

About Adtalem Global Education

Adtalem Global Education is the leading provider of healthcare education in the U.S., shaping the future of healthcare by preparing a diverse workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and inclusivity is reflected in our expansive network of institutions, serving over 90,000 students and supported by a strong community of approximately 350,000 alumni and nearly 10,000 dedicated employees. Visit Adtalem.com for more information and follow us on LinkedIn, Instagram and Facebook.

Cautionary Disclosure Regarding Forward-Looking Statements

Certain statements contained in this release are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, which includes statements regarding Adtalem’s future growth. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “future,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “may,” “will,” “would,” “could,” “can,” “continue,” “preliminary,” “range,” and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include the risk factors described in Item 1A. “Risk Factors” of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC. These forward-looking statements are based on information available to us as of the date any such statements are made, and Adtalem assumes no obligation to publicly update or revise its forward-


looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized, except as required by law.

A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of special items that may be incurred in the future, although these special items could be material to Adtalem's results in accordance with GAAP.

1 Represents total students attending sessions during each institution’s most recent enrollment period in Q2 FY 2025 and Q2 FY 2024.

###


Adtalem Global Education Inc.

Consolidated Balance Sheets

(unaudited)

(in thousands)

December 31,

June 30,

    

2024

2024

Assets:

Current assets:

Cash and cash equivalents

$

193,958

$

219,306

Restricted cash

 

1,461

 

1,896

Accounts and financing receivables, net

 

146,973

 

126,833

Prepaid expenses and other current assets

 

64,693

 

70,050

Total current assets

 

407,085

 

418,085

Noncurrent assets:

 

  

 

  

Property and equipment, net

 

245,878

 

248,524

Operating lease assets

 

188,800

 

176,755

Deferred income taxes

 

28,413

 

49,088

Intangible assets, net

 

771,084

 

776,694

Goodwill

 

961,262

 

961,262

Other assets, net

 

112,608

 

103,184

Assets held for sale

 

7,825

 

7,825

Total noncurrent assets

 

2,315,870

 

2,323,332

Total assets

$

2,722,955

$

2,741,417

Liabilities and shareholders' equity:

 

  

 

  

Current liabilities:

 

  

 

  

Accounts payable

$

66,920

$

102,626

Accrued payroll and benefits

 

50,999

 

71,373

Accrued liabilities

 

62,479

 

96,957

Deferred revenue

 

171,523

 

185,272

Current operating lease liabilities

 

32,633

 

31,429

Total current liabilities

 

384,554

 

487,657

Noncurrent liabilities:

 

 

Long-term debt

 

649,924

 

648,712

Long-term operating lease liabilities

 

182,051

 

167,712

Deferred income taxes

 

32,367

 

29,526

Other liabilities

 

35,149

 

38,675

Total noncurrent liabilities

 

899,491

 

884,625

Total liabilities

 

1,284,045

 

1,372,282

Commitments and contingencies

 

 

Total shareholders' equity

 

1,438,910

 

1,369,135

Total liabilities and shareholders' equity

$

2,722,955

$

2,741,417


Adtalem Global Education Inc.

Consolidated Statements of Income

(unaudited)

(in thousands, except per share data)

Three Months Ended

Six Months Ended

December 31,

December 31,

2024

2023

2024

2023

Revenue

$

447,729

$

393,242

$

865,129

$

762,087

Operating cost and expense:

 

 

Cost of educational services

 

186,636

 

172,069

 

372,631

 

340,687

Student services and administrative expense

 

156,901

 

155,584

 

315,974

 

321,679

Restructuring expense

 

322

 

68

 

2,416

 

744

Business integration expense

 

 

6,909

 

 

12,171

Total operating cost and expense

 

343,859

 

334,630

 

691,021

 

675,281

Operating income

 

103,870

 

58,612

 

174,108

 

86,806

Interest expense

 

(13,909)

 

(16,693)

 

(28,391)

 

(32,350)

Other income, net

 

2,235

 

3,563

 

4,881

 

5,777

Income from continuing operations before income taxes

 

92,196

 

45,482

 

150,598

 

60,233

Provision for income taxes

 

(21,020)

 

(7,769)

 

(33,177)

 

(10,561)

Income from continuing operations

 

71,176

 

37,713

 

117,421

 

49,672

Discontinued operations:

 

 

Income from discontinued operations before income taxes

 

6,271

 

2,926

 

6,164

 

1,161

Provision for income taxes

 

(1,591)

 

(748)

 

(1,564)

 

(296)

Income from discontinued operations

 

4,680

 

2,178

 

4,600

 

865

Net income and comprehensive income

$

75,856

$

39,891

$

122,021

$

50,537

Earnings per share:

 

 

Basic:

 

 

Continuing operations

$

1.90

$

0.95

$

3.12

$

1.22

Discontinued operations

$

0.13

$

0.05

$

0.12

$

0.02

Total basic earnings per share

$

2.03

$

1.00

$

3.25

$

1.24

Diluted:

 

 

 

 

Continuing operations

$

1.85

$

0.92

$

3.03

$

1.20

Discontinued operations

$

0.12

$

0.05

$

0.12

$

0.02

Total diluted earnings per share

$

1.98

$

0.98

$

3.15

$

1.22

Weighted-average shares outstanding:

Basic shares

37,435

39,872

37,578

40,636

Diluted shares

38,401

40,787

38,755

41,486


Adtalem Global Education Inc.

Consolidated Statements of Cash Flows
(unaudited)

(in thousands)

Six Months Ended

December 31,

2024

2023

Operating activities:

Net income

$

122,021

$

50,537

Income from discontinued operations

 

(4,600)

 

(865)

Income from continuing operations

117,421

49,672

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

Stock-based compensation

 

20,918

 

13,505

Amortization and impairments to operating lease assets

14,092

17,340

Depreciation

 

19,993

 

19,381

Amortization of acquired intangible assets

 

5,610

 

20,010

Amortization of debt discount and issuance costs

2,226

2,310

Provision for bad debts

28,719

23,024

Deferred income taxes

 

23,516

 

(343)

Loss on disposals of property and equipment

 

114

 

38

Gain on investments

(442)

(575)

Unrealized loss on assets held for sale

647

Changes in assets and liabilities:

 

 

Accounts and financing receivables

 

(46,493)

 

(52,716)

Prepaid expenses and other current assets

 

6,829

 

(2,143)

Cloud computing implementation assets

 

(14,071)

 

(11,314)

Accounts payable

 

(34,588)

 

9,755

Accrued payroll and benefits

(20,311)

(6,073)

Accrued liabilities

 

(29,066)

 

25,130

Deferred revenue

 

(12,028)

 

(13,540)

Operating lease liabilities

(10,594)

(20,441)

Other assets and liabilities

 

(5,888)

 

(1,314)

Net cash provided by operating activities-continuing operations

 

65,957

 

72,353

Net cash provided by operating activities-discontinued operations

 

4,340

 

9,515

Net cash provided by operating activities

 

70,297

 

81,868

Investing activities:

 

Capital expenditures

 

(21,094)

 

(19,612)

Proceeds from sales of marketable securities

 

2,426

 

626

Purchases of marketable securities

 

(1,548)

 

(498)

Net cash used in investing activities

 

(20,216)

 

(19,484)

Financing activities:

 

Proceeds from exercise of stock options

 

9,833

 

15,313

Employee taxes paid on withholding shares

 

(12,198)

 

(6,505)

Proceeds from stock issued under Colleague Stock Purchase Plan

 

567

 

359

Repurchases of common stock for treasury

 

(74,066)

 

(160,549)

Proceeds from issuance of long-term debt

 

9,873

 

Repayments of long-term debt

 

(9,873)

 

Net cash used in financing activities

 

(75,864)

 

(151,382)

Net decrease in cash, cash equivalents and restricted cash

 

(25,783)

 

(88,998)

Cash, cash equivalents and restricted cash at beginning of period

 

221,202

 

275,075

Cash, cash equivalents and restricted cash at end of period

$

195,419

$

186,077

Non-cash investing and financing activities:

Accrued capital expenditures

$

5,085

$

4,053

Accrued liability for repurchases of common stock

$

400

$

2,400

Accrued excise tax on share repurchases

$

301

$

2,358


Adtalem Global Education Inc.

Segment Information

(unaudited)

(in thousands)

Three Months Ended

Six Months Ended

December 31,

December 31,

Increase/(Decrease)

Increase/(Decrease)

    

2024

2023

    

$

%

    

2024

2023

    

$

%

Revenue:

Chamberlain

$

180,986

$

153,553

$

27,433

17.9

%

$

348,916

$

296,149

$

52,767

17.8

%

Walden

171,306

146,808

24,498

16.7

%

332,819

288,416

44,403

15.4

%

Medical and Veterinary

95,437

92,881

2,556

2.8

%

183,394

177,522

5,872

3.3

%

Total consolidated revenue

$

447,729

$

393,242

$

54,487

13.9

%

$

865,129

$

762,087

$

103,042

13.5

%

Operating income (loss):

Chamberlain

$

42,226

$

29,640

$

12,586

42.5

%

$

68,200

$

53,964

$

14,236

26.4

%

Walden

48,898

21,598

27,300

126.4

%

88,735

23,536

65,199

277.0

%

Medical and Veterinary

21,463

22,020

(557)

(2.5)

%

36,134

36,383

(249)

(0.7)

%

Home Office

(8,717)

(14,646)

5,929

40.5

%

(18,961)

(27,077)

8,116

30.0

%

Total consolidated operating income

$

103,870

$

58,612

$

45,258

77.2

%

$

174,108

$

86,806

$

87,302

100.6

%

Non-GAAP Financial Measures and Reconciliations

We believe that certain non-GAAP financial measures provide investors with useful supplemental information regarding the underlying business trends and performance of Adtalem’s ongoing operations as seen through the eyes of management and are useful for period-over-period comparisons. We use these supplemental non-GAAP financial measures internally in our assessment of performance and budgeting process. However, these non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. The following are non-GAAP financial measures used in the subsequent GAAP to non-GAAP reconciliation tables:

Adjusted net income (most comparable GAAP measure: net income) – Measure of Adtalem’s net income adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, litigation reserve, debt modification costs, loss on assets held for sale, and income from discontinued operations.

Adjusted earnings per share (most comparable GAAP measure: diluted earnings per share) – Measure of Adtalem’s diluted earnings per share adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, litigation reserve, debt modification costs, loss on assets held for sale, and income from discontinued operations.

Adjusted operating income (most comparable GAAP measure: operating income) – Measure of Adtalem’s operating income adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, litigation reserve, debt modification costs, and loss on assets held for sale. This measure is applied on a consolidated and segment basis, depending on the context of the discussion.

Adjusted EBITDA (most comparable GAAP measure: net income) – Measure of Adtalem’s net income adjusted for income from discontinued operations, interest expense, other income, net, provision for income taxes, depreciation, amortization of acquired intangible assets, amortization of cloud computing implementation assets, stock-based compensation, restructuring expense, business integration expense, litigation reserve, loss on assets held for sale, and debt modification costs. This measure is applied on a consolidated and segment basis, depending on the context of the discussion. Provision for income taxes, interest expense, and other income, net is not recorded at the reportable segments, and therefore, the segment adjusted EBITDA reconciliations begin with operating income.

Free cash flow (most comparable GAAP measure: net cash provided by operating activities-continuing operations) – Defined as net cash provided by operating activities-continuing operations less capital expenditures.

Net debt – Defined as long-term debt less cash and cash equivalents.

Net leverage – Defined as net debt divided by adjusted EBITDA.


A description of special items in our non-GAAP financial measures described above are as follows:

Restructuring expense primarily related to workforce reductions, costs to exit certain course offerings, and prior real estate consolidations at Adtalem’s home office. We do not include normal, recurring, cash operating expenses in our restructuring expense.
Business integration expense include expenses related to the Walden acquisition and certain costs related to growth transformation initiatives. We do not include normal, recurring, cash operating expenses in our business integration expense.
Amortization of acquired intangible assets.
Amortization of cloud computing implementation assets.
Reserves related to significant litigation, debt modification costs related to refinancing our Term Loan B loan, and loss on assets held for sale related to a fair value write-down on assets.
Income from discontinued operations includes expense from ongoing litigation costs and settlements related to the DeVry University divestiture and the earn-outs we received.

Adtalem Global Education Inc.

Non-GAAP Operating Income by Segment

(unaudited)

(in thousands)

Three Months Ended

Six Months Ended

December 31,

December 31,

Increase/(Decrease)

Increase/(Decrease)

2024

2023

$

%

2024

2023

$

%

Chamberlain:

Operating income (GAAP)

$

42,226

$

29,640

$

12,586

42.5

%

$

68,200

$

53,964

$

14,236

26.4

%

Restructuring expense

77

77

1,935

1,935

Adjusted operating income (non-GAAP)

$

42,303

$

29,640

$

12,663

42.7

%

$

70,135

$

53,964

$

16,171

30.0

%

Operating margin (GAAP)

23.3

%

19.3

%

19.5

%

18.2

%

Operating margin (non-GAAP)

23.4

%

19.3

%

20.1

%

18.2

%

Walden:

Operating income (GAAP)

$

48,898

$

21,598

$

27,300

126.4

%

$

88,735

$

23,536

$

65,199

277.0

%

Restructuring expense

(776)

776

(776)

776

Amortization of acquired intangible assets

2,805

9,333

(6,528)

5,610

20,010

(14,400)

Litigation reserve

(5,550)

(5,550)

(5,550)

18,500

(24,050)

Adjusted operating income (non-GAAP)

$

46,153

$

30,155

$

15,998

53.1

%

$

88,795

$

61,270

$

27,525

44.9

%

Operating margin (GAAP)

28.5

%

14.7

%

26.7

%

8.2

%

Operating margin (non-GAAP)

26.9

%

20.5

%

26.7

%

21.2

%

Medical and Veterinary:

Operating income (GAAP)

$

21,463

$

22,020

$

(557)

(2.5)

%

$

36,134

$

36,383

$

(249)

(0.7)

%

Restructuring expense

56

71

(15)

115

185

(70)

Adjusted operating income (non-GAAP)

$

21,519

$

22,091

$

(572)

(2.6)

%

$

36,249

$

36,568

$

(319)

(0.9)

%

Operating margin (GAAP)

22.5

%

23.7

%

19.7

%

20.5

%

Operating margin (non-GAAP)

22.5

%

23.8

%

19.8

%

20.6

%

Home Office:

Operating loss (GAAP)

$

(8,717)

$

(14,646)

$

5,929

40.5

%

$

(18,961)

$

(27,077)

$

8,116

30.0

%

Restructuring expense

189

773

(584)

366

1,335

(969)

Business integration expense

6,909

(6,909)

12,171

(12,171)

Loss on assets held for sale

647

(647)

647

(647)

Debt modification costs

712

712

Adjusted operating loss (non-GAAP)

$

(8,528)

$

(6,317)

$

(2,211)

(35.0)

%

$

(17,883)

$

(12,924)

$

(4,959)

(38.4)

%

Adtalem Global Education:

Operating income (GAAP)

$

103,870

$

58,612

$

45,258

77.2

%

$

174,108

$

86,806

$

87,302

100.6

%

Restructuring expense

322

68

254

2,416

744

1,672

Business integration expense

6,909

(6,909)

12,171

(12,171)

Amortization of acquired intangible assets

2,805

9,333

(6,528)

5,610

20,010

(14,400)

Litigation reserve

(5,550)

(5,550)

(5,550)

18,500

(24,050)

Loss on assets held for sale

647

(647)

647

(647)

Debt modification costs

712

712

Adjusted operating income (non-GAAP)

$

101,447

$

75,569

$

25,878

34.2

%

$

177,296

$

138,878

$

38,418

27.7

%

Operating margin (GAAP)

23.2

%

14.9

%

20.1

%

11.4

%

Operating margin (non-GAAP)

22.7

%

19.2

%

20.5

%

18.2

%


Adtalem Global Education Inc.

Non-GAAP Adjusted EBITDA by Segment

(unaudited)

(in thousands)

Three Months Ended

Six Months Ended

December 31,

December 31,

Increase/(Decrease)

Increase/(Decrease)

2024

2023

$

%

2024

2023

$

%

Chamberlain:

Operating income (GAAP)

$

42,226

$

29,640

$

12,586

42.5

%

$

68,200

$

53,964

$

14,236

26.4

%

Restructuring expense

77

77

1,935

1,935

Depreciation

5,466

4,786

680

10,834

8,902

1,932

Amortization of cloud computing implementation assets

815

376

439

1,467

576

891

Stock-based compensation

3,993

2,089

1,904

7,112

4,996

2,116

Adjusted EBITDA (non-GAAP)

$

52,577

$

36,891

$

15,686

42.5

%

$

89,548

$

68,438

$

21,110

30.8

%

Adjusted EBITDA margin (non-GAAP)

29.1

%

24.0

%

25.7

%

23.1

%

Walden:

Operating income (GAAP)

$

48,898

$

21,598

$

27,300

126.4

%

$

88,735

$

23,536

$

65,199

277.0

%

Restructuring expense

(776)

776

(776)

776

Amortization of acquired intangible assets

2,805

9,333

(6,528)

5,610

20,010

(14,400)

Litigation reserve

(5,550)

(5,550)

(5,550)

18,500

(24,050)

Depreciation

1,795

1,926

(131)

3,477

3,900

(423)

Amortization of cloud computing implementation assets

778

379

399

1,479

567

912

Stock-based compensation

3,326

2,188

1,138

6,066

4,052

2,014

Adjusted EBITDA (non-GAAP)

$

52,052

$

34,648

$

17,404

50.2

%

$

99,817

$

69,789

$

30,028

43.0

%

Adjusted EBITDA margin (non-GAAP)

30.4

%

23.6

%

30.0

%

24.2

%

Medical and Veterinary:

Operating income (GAAP)

$

21,463

$

22,020

$

(557)

(2.5)

%

$

36,134

$

36,383

$

(249)

(0.7)

%

Restructuring expense

56

71

(15)

115

185

(70)

Depreciation

2,744

2,972

(228)

5,313

5,864

(551)

Amortization of cloud computing implementation assets

315

138

177

598

190

408

Stock-based compensation

2,158

1,196

962

3,765

2,836

929

Adjusted EBITDA (non-GAAP)

$

26,736

$

26,397

$

339

1.3

%

$

45,925

$

45,458

$

467

1.0

%

Adjusted EBITDA margin (non-GAAP)

28.0

%

28.4

%

25.0

%

25.6

%

Home Office:

Operating loss (GAAP)

$

(8,717)

$

(14,646)

$

5,929

40.5

%

$

(18,961)

$

(27,077)

$

8,116

30.0

%

Restructuring expense

189

773

(584)

366

1,335

(969)

Business integration expense

6,909

(6,909)

12,171

(12,171)

Loss on assets held for sale

647

(647)

647

(647)

Debt modification costs

712

712

Depreciation

185

359

(174)

369

715

(346)

Stock-based compensation

1,990

577

1,413

3,975

1,621

2,354

Adjusted EBITDA (non-GAAP)

$

(6,353)

$

(5,381)

$

(972)

(18.1)

%

$

(13,539)

$

(10,588)

$

(2,951)

(27.9)

%

Adtalem Global Education:

Net income (GAAP)

$

75,856

$

39,891

$

35,965

90.2

%

$

122,021

$

50,537

$

71,484

141.4

%

Income from discontinued operations

(4,680)

(2,178)

(2,502)

(4,600)

(865)

(3,735)

Interest expense

13,909

16,693

(2,784)

28,391

32,350

(3,959)

Other income, net

(2,235)

(3,563)

1,328

(4,881)

(5,777)

896

Provision for income taxes

21,020

7,769

13,251

33,177

10,561

22,616

Operating income (GAAP)

103,870

58,612

45,258

174,108

86,806

87,302

Depreciation and amortization

14,903

20,269

(5,366)

29,147

40,724

(11,577)

Stock-based compensation

11,467

6,050

5,417

20,918

13,505

7,413

Restructuring expense

322

68

254

2,416

744

1,672

Business integration expense

6,909

(6,909)

12,171

(12,171)

Litigation reserve

(5,550)

(5,550)

(5,550)

18,500

(24,050)

Loss on assets held for sale

647

(647)

647

(647)

Debt modification costs

712

712

Adjusted EBITDA (non-GAAP)

$

125,012

$

92,555

$

32,457

35.1

%

$

221,751

$

173,097

$

48,654

28.1

%

Adjusted EBITDA margin (non-GAAP)

27.9

%

23.5

%

25.6

%

22.7

%


Adtalem Global Education Inc.

Non-GAAP Earnings Disclosure

(unaudited)

(in thousands, except per share data)

Three Months Ended

Six Months Ended

December 31,

December 31,

2024

2023

2024

2023

Net income (GAAP)

$

75,856

$

39,891

$

122,021

$

50,537

Restructuring expense

322

68

2,416

744

Business integration expense

6,909

12,171

Amortization of acquired intangible assets

2,805

9,333

5,610

20,010

Litigation reserve, debt modification costs, and loss on assets held for sale

(5,550)

647

(4,838)

19,147

Income tax impact on non-GAAP adjustments (1)

645

(4,402)

(687)

(12,095)

Income from discontinued operations

(4,680)

(2,178)

(4,600)

(865)

Adjusted net income (non-GAAP)

$

69,398

$

50,268

$

119,922

$

89,649

(1)Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.

Three Months Ended

Six Months Ended

December 31,

December 31,

2024

2023

2024

2023

Diluted earnings per share (GAAP)

$

1.98

$

0.98

$

3.15

$

1.22

Effect on diluted earnings per share:

Restructuring expense

0.01

0.00

0.06

0.02

Business integration expense

-

0.17

-

0.29

Amortization of acquired intangible assets

0.07

0.23

0.14

0.48

Litigation reserve, debt modification costs, and loss on assets held for sale

(0.14)

0.02

(0.12)

0.46

Income tax impact on non-GAAP adjustments (1)

0.02

(0.11)

(0.02)

(0.29)

Income from discontinued operations

(0.12)

(0.05)

(0.12)

(0.02)

Adjusted earnings per share (non-GAAP)

$

1.81

$

1.23

$

3.09

$

2.16

Diluted shares used in non-GAAP EPS calculation

38,401

40,787

38,755

41,486

Note: May not sum due to rounding.

(1)Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.


Adtalem Global Education Inc.

Non-GAAP Free Cash Flow Disclosure

(unaudited)

(in thousands)

Twelve Months Ended

FY24

FY24

FY24

FY25

FY25

    

Q2

Q3

Q4

Q1

Q2

Net cash provided by (used in) operating activities-continuing operations (GAAP)

$

227,600

$

276,843

$

288,367

$

291,820

$

281,971

Capital expenditures

(38,713)

(44,137)

(48,893)

(48,873)

(50,375)

Free cash flow (non-GAAP)

$

188,887

$

232,706

$

239,474

$

242,947

$

231,596

Adtalem Global Education Inc.

Non-GAAP Net Leverage Disclosure

(unaudited)

(in thousands)

Twelve Months Ended

December 31, 2024

Adtalem Global Education:

Net income (GAAP)

$

208,261

Income from discontinued operations

(2,799)

Interest expense

59,700

Other income, net

(9,646)

Provision for income taxes

48,840

Depreciation and amortization

66,875

Stock-based compensation

33,360

Restructuring expense

3,542

Business integration expense

22,044

Litigation reserve

(5,550)

Debt modification costs

1,560

Adjusted EBITDA (non-GAAP)

$

426,187

December 31, 2024

Long-term debt

$

658,283

Less: Cash and cash equivalents

(193,958)

Net debt (non-GAAP)

$

464,325

Net leverage (non-GAAP)

1.1 x


v3.24.4
Document and Entity Information
Jan. 30, 2025
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Jan. 30, 2025
Entity File Number 001-13988
Entity Registrant Name ADTALEM GLOBAL EDUCATION INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 36-3150143
Entity Address, Address Line One 500 West Monroe
Entity Address, City or Town Chicago
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60661
City Area Code 312
Local Phone Number 651-1400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000730464
Amendment Flag false
New York Stock Exchange  
Document Information [Line Items]  
Title of 12(b) Security Common Stock $0.01 Par Value
Trading Symbol ATGE
Security Exchange Name NYSE
Chicago Stock Exchange  
Document Information [Line Items]  
Title of 12(b) Security Common Stock $0.01 Par Value
Trading Symbol ATGE
Security Exchange Name CHX

Adtalem Global Education (NYSE:ATGE)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse Adtalem Global Education
Adtalem Global Education (NYSE:ATGE)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse Adtalem Global Education